Advertisement
Screener

XTANT MEDICAL HOLDINGS, INC. (XTNT) Cost of Goods Sold (Deprecated 2018-01-31)

1.8 / 5 stars · 43/120 Roast Me

XTANT MEDICAL HOLDINGS, INC. Cost of Goods Sold (Deprecated 2018-01-31)

XTANT MEDICAL HOLDINGS, INC. (XTNT) reported Cost of Goods Sold (Deprecated 2018-01-31) of $1.86 million for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-04.

Discontinued › Expense Statement › Cost of Sales

us-gaap:CostOfGoodsSold · last filed 2012-05-04

  • XTANT MEDICAL HOLDINGS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2012-03-31 was $1.86M, a 88.25% increase year-over-year.
  • XTANT MEDICAL HOLDINGS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2011-12-31 was $5.06M, a 230.60% increase year-over-year.
  • XTANT MEDICAL HOLDINGS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2011-09-30 was $1.32M, a 85.41% increase year-over-year.
  • XTANT MEDICAL HOLDINGS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2011-06-30 was $1.74M, a 235.62% increase year-over-year.
  • XTANT MEDICAL HOLDINGS, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2011 was $9.11M, a 170.80% increase from fiscal 2010.
  • XTANT MEDICAL HOLDINGS, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2010 was $3.36M.
Period endCost of Goods Sold (Deprecated 2018-01-31) 3 monthCost of Goods Sold (Deprecated 2018-01-31) 6 monthCost of Goods Sold (Deprecated 2018-01-31) 9 monthCost of Goods Sold (Deprecated 2018-01-31) 12 month
2012-03-31$1.86M
10-Q · filed 2012-05-04
$6.92M
derived: sum of 2 quarters · filed 2012-05-04
$8.24M
derived: sum of 3 quarters · filed 2012-05-04
$9.98M
derived: sum of 4 quarters · filed 2012-05-04
2011-12-31$5.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29
$6.38M
derived: sum of 2 quarters · filed 2012-03-29
$8.12M
derived: sum of 3 quarters · filed 2012-03-29
$9.11M
10-K · filed 2012-03-29
2011-09-30$1.32M
10-Q · filed 2011-11-14
$3.06M
derived: sum of 2 quarters · filed 2011-11-14
$4.05M
10-Q · filed 2011-11-14
$5.58M
derived: sum of 4 quarters · filed 2012-05-04
2011-06-30$1.74M
10-Q · filed 2011-08-15
$2.73M
10-Q · filed 2011-08-15
$4.26M
derived: sum of 3 quarters · filed 2012-05-04
$4.97M
derived: sum of 4 quarters · filed 2012-05-04
2011-03-31$987.36K
10-Q · filed 2012-05-04
$2.52M
derived: sum of 2 quarters · filed 2012-05-04
$3.23M
derived: sum of 3 quarters · filed 2012-05-04
$3.75M
derived: sum of 4 quarters · filed 2012-05-04
2010-12-31$1.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29
$2.24M
derived: sum of 2 quarters · filed 2012-03-29
$2.76M
derived: sum of 3 quarters · filed 2012-03-29
$3.36M
10-K · filed 2012-03-29
2010-09-30$711.17K
10-Q · filed 2011-11-14
$1.23M
derived: sum of 2 quarters · filed 2011-11-14
$1.83M
10-Q · filed 2011-11-14
2010-06-30$519.08K
10-Q · filed 2011-08-15
$1.12M
10-Q · filed 2011-08-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Spectral AI, Inc. (MDAI)United States$0.052B
TELA Bio, Inc. (TELA)United States$0.057B-0.82
Sensus Healthcare, Inc. (SRTS)United States$0.048B-3.24
NEPHROS INC (NEPH)United States$0.046B23.02
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47
DarioHealth Corp. (DRIO)$0.066B-1.39
CVRx, Inc. (CVRX)United States$0.067B-2.62
InspireMD, Inc. (NSPR)$0.033B
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18
PAVmed Inc. (PAVM)United States$0.031B-3.00